Insider

Texas Instruments financial results, Union Pacific operating metrics, and BeOne Medicines share sale

Texas Instruments reported higher key financial metrics, Union Pacific showed increased shipping volumes, and a BeOne Medicines director sold all his shares.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
concrete building with USA flags
Photo by Aditya Vyas on Unsplash

Texas Instruments revenue rose to $6.06 billion

Texas Instruments reported third-quarter revenue of $6.06 billion, a 28% increase from the same period last year. Operating profit rose 73%, and net income increased 78%. Management cited demand in the industrial, automotive, and data center sectors.

BeOne Medicines director sold all his shares

Wang Xiaodong, a director and chair of the scientific advisory board at BeOne Medicines, sold all his shares in the company on October 13, 2026. He disposed of 31,027 shares for a total of $10.89 million at an average price of $350.99 per share. Following the transaction, his stake is zero. The sale was made under a Rule 10b5-1 trading plan, a preset selling schedule executives set up in advance.

Union Pacific third-quarter operating metrics

Union Pacific increased shipping volumes by 6% in the third quarter. Freight car velocity rose 1%, and terminal dwell time decreased by 2%.

Original sources

  1. Texas Instruments Inc: 8-K EX-99 filing, October 21, 2026October 21, 2026SHA-256 of our archived copy ac247ea8fa6f…
  2. BeOne Medicines Ltd.: 4 filing, October 15, 2026October 15, 2026SHA-256 of our archived copy 43835d87acdf…
  3. Jim Vena: Moving America ForwardOctober 22, 2026SHA-256 of our archived copy 30735df3f12c…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards